Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. It develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer...
17 insider purchases on record · latest filing 2026-08-19.
Insiders have also filed 447 sale transactions at ZNTL.